Please login to the form below

Not currently logged in
Email:
Password:

talimogene laherparepvec

This page shows the latest talimogene laherparepvec news and features for those working in and with pharma, biotech and healthcare.

NICE turns down CDF drug Adcetris in draft guidance

NICE turns down CDF drug Adcetris in draft guidance

Imlygic (talimogene laherparepvec) was turned down by NICE in earlier guidance, with the agency arguing that it could not justify its use because of uncertainty about the therapy's effects on

Latest news

More from news
Approximately 4 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Spoonful of Sugar

Spoonful of Sugar (SoS) is a unique and diverse team of specialists in illness and medicines-related behaviour, hand-picked from academic,...

Latest intelligence

Market access improvements in Turkey
...
annual-marketing-summit.jpg
Showcasing our multichannel capabilities in Berlin
Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications...
What is MaxDiff?
MaxDiff - (aka maximum difference scaling) can help market researchers pare down a wealth of information into precise and actionable insights. Sarah Mackinnon, Research Manager at Creative Medical Research, looks...

Infographics